Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 9Central Nervous System Neoplasms 6Medulloblastoma 4Astrocytoma 4Oligodendroglioma 3Lymphoma 3Leukemia 2Inflammatory Breast Neoplasms 2Ganglioneuroblastoma 2Brain Neoplasms 2Thrombocythemia, Essential 1Rhabdoid Tumor 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pinealoma 1Ovarian Neoplasms 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Familial ependymoma 1Fallopian Tube Neoplasms 1

Interventions

Temozolomide 6O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Filgrastim 3Vorinostat 2Specimen Handling 2Radiotherapy 2Oxaliplatin 2Irinotecan 2Erlotinib Hydrochloride 2Carboplatin 2veliparib 1sargramostim 1romidepsin 1phenylacetic acid 1pembrolizumab 1palbociclib 1olaparib 1ixabepilone 1ispinesib 1erdafitinib 1cediranib 1becatecarin 1alvocidib 1X-Rays 1Verteporfin 1Thiotepa 1Tamoxifen 1Sunitinib 1RMP 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Familial ependymoma × Thiotepa × Clear all
NCT00008008 2013-02-04

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡